{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:46:21Z","timestamp":1787964381424,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although there are many results that can be used to treat and prevent Coronavirus Disease 2019 (COVID-19) and Human Immunodeficiency Virus (HIV), these diseases continue to be public health concerns and cause socioeconomic consequences. Following compromised immunity, COVID-19 is considered to be a challenge for people with HIV. People with advanced HIV are considered a vulnerable population at high risk in several case studies that discuss COVID-19 and HIV co-infection. As there is no cure for HIV and there is a chance of contracting COVID-19 again, co-infection continues to pose a problem. The purpose of this study is to investigate the impact of intervention strategies and identify the role of different parameters in risking people living with HIV to death when they get infected with COVID-19. This is achieved through the development and rigorous analysis of a mathematical model that considers a population at risk of death due to COVID-19 and HIV. The model formulation provides a detailed explanation of the transmission dynamics of COVID-19 and HIV co-infection. The solution\u2019s invariant region, positivity, and boundedness were established. The reproduction numbers of the sub-models and the co-infection model were determined. The existence and stability of equilibria, including backward bifurcation for the COVID-19 sub-model, were examined. The epidemiological significance of backward bifurcation is that the condition <jats:inline-formula><jats:alternatives><jats:tex-math>$${\\mathscr {R}}_0$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:msub>\n                    <mml:mi>R<\/mml:mi>\n                    <mml:mn>0<\/mml:mn>\n                  <\/mml:msub>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> less than 1 for eliminating COVID-19, though necessary, is no longer sufficient. Parametric estimation and curve fitting were performed based on data from Ethiopia. Numerical simulations were employed to support and clarify the analytical findings and to show some parameter effects on COVID-19 and HIV co-infection. Accordingly, the simulations indicated that parameters <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\gamma _c$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:msub>\n                    <mml:mi>\u03b3<\/mml:mi>\n                    <mml:mi>c<\/mml:mi>\n                  <\/mml:msub>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>, <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\gamma _h$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:msub>\n                    <mml:mi>\u03b3<\/mml:mi>\n                    <mml:mi>h<\/mml:mi>\n                  <\/mml:msub>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>, <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\epsilon$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03f5<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>, and <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\kappa$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03ba<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>, related to HIV patients\u2019 exposure to other diseases and the increase in infectiousness, have a positive role in increasing the number of co-infections. On the other hand, an increase in COVID-19 vaccination (<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\xi$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03be<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>) shows the suppression of co-infection cases. In addition, treating co-infected individuals for COVID-19, increasing treatment rates <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\alpha$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03b1<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula> and <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\varphi$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mi>\u03c6<\/mml:mi>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>, reduces the death risk of HIV-infected individuals due to the co-infection burden. It was implied that improving vaccine delivery programs and other medical interventions have important contributions to lowering the risk of COVID-19 infection-related fatalities in HIV patients.<\/jats:p>","DOI":"10.1038\/s41598-023-45520-6","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:02:15Z","timestamp":1698411735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Co-infection dynamics of COVID-19 and HIV\/AIDS"],"prefix":"10.1038","volume":"13","author":[{"given":"Tesfaneh Debele","family":"Batu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Legesse Lemecha","family":"Obsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chernet Tuge","family":"Deressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"45520_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9 (2020).","journal-title":"Lancet"},{"key":"45520_CR2","unstructured":"WHO. Global HIV Programme 2020 estimates. https:\/\/bit.ly\/3HmxDpQ (2022)."},{"key":"45520_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","volume":"384","author":"G Maartens","year":"2014","unstructured":"Maartens, G., Celum, C. & Lewin, S. R. HIV infection: Epidemiology, pathogenesis, treatment, and prevention. Lancet 384, 258\u2013271. https:\/\/doi.org\/10.1016\/S0140-6736(14)60164-1 (2014).","journal-title":"Lancet"},{"key":"45520_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/bmb\/58.1.7","volume":"58","author":"L Morison","year":"2001","unstructured":"Morison, L. The global epidemiology of HIV\/AIDS. Br. Med. Bull. 58, 7\u201318. https:\/\/doi.org\/10.1093\/bmb\/58.1.7 (2001).","journal-title":"Br. Med. Bull."},{"key":"45520_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","volume":"368","author":"V Simon","year":"2006","unstructured":"Simon, V., Ho, D. D. & Karim, Q. A. HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368, 489\u2013504. https:\/\/doi.org\/10.1016\/S0140-6736(06)69157-5 (2006).","journal-title":"Lancet"},{"key":"45520_CR6","unstructured":"Centers for Disease Control and Prevention and others. Evidence of HIV treatment and viral suppression in preventing the sexual transmission of HIV. Dep. Health Hum. Serv. 10 (2018)."},{"key":"45520_CR7","unstructured":"WHO. Global situation. https:\/\/covid19.who.int\/ (2022)."},{"key":"45520_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.07.014","author":"H Ejaz","year":"2020","unstructured":"Ejaz, H. et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Healthhttps:\/\/doi.org\/10.1016\/j.jiph.2020.07.014 (2020).","journal-title":"J. Infect. Public Health"},{"key":"45520_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-82862-5","volume":"11","author":"S Elezkurtaj","year":"2021","unstructured":"Elezkurtaj, S. et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci. Rep. 11, 1\u20139. https:\/\/doi.org\/10.1038\/s41598-021-82862-5 (2021).","journal-title":"Sci. Rep."},{"key":"45520_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-85359-3","volume":"11","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo, P. et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: A systematic review and meta-analysis. Sci. Rep. 11, 1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-85359-3 (2021).","journal-title":"Sci. Rep."},{"key":"45520_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10461-020-02983-2","volume":"25","author":"H Mirzaei","year":"2021","unstructured":"Mirzaei, H., McFarland, W., Karamouzian, M. & Sharifi, H. COVID-19 among people living with HIV: a systematic review. AIDS Behav. 25, 85\u201392. https:\/\/doi.org\/10.1007\/s10461-020-02983-2 (2021).","journal-title":"AIDS Behav."},{"key":"45520_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/v13050931","volume":"13","author":"CM Gonz\u00e1lez-Domenech","year":"2021","unstructured":"Gonz\u00e1lez-Domenech, C. M. et al. A pandemic within other pandemics. When a multiple infection of a host occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis. Viruses 13, 931. https:\/\/doi.org\/10.3390\/v13050931 (2021).","journal-title":"Viruses"},{"key":"45520_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/IMCRJ.S326383","volume":"14","author":"T Tolossa","year":"2021","unstructured":"Tolossa, T. et al. Survival from a triple co-infection of COVID-19, HIV, and tuberculosis: A case report. Int. Med. Case Rep. J. 14, 611. https:\/\/doi.org\/10.2147\/IMCRJ.S326383 (2021).","journal-title":"Int. Med. Case Rep. J."},{"key":"45520_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00335-1","volume":"18","author":"S Gatechompol","year":"2021","unstructured":"Gatechompol, S., Avihingsanon, A., Putcharoen, O., Ruxrungtham, K. & Kuritzkes, D. R. COVID-19 and HIV infection co-pandemics and their impact: A review of the literature. AIDS Res. Ther. 18, 1\u20139 (2021).","journal-title":"AIDS Res. Ther."},{"key":"45520_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jmv.26321","volume":"93","author":"ON Kanwugu","year":"2021","unstructured":"Kanwugu, O. N. & Adadi, P. HIV\/SARS-CoV-2 coinfection: A global perspective. J. Med. Virol. 93, 726\u2013732. https:\/\/doi.org\/10.1002\/jmv.26321 (2021).","journal-title":"J. Med. Virol."},{"key":"45520_CR16","unstructured":"WHO. Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection, 15 July 2021. Technical documents, World Health Organization (2021)."},{"key":"45520_CR17","unstructured":"WHO. COVID-19 advice for the public: Getting vaccinated. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines\/advice (2022)."},{"key":"45520_CR18","unstructured":"WHO. Episode 48: HIV and COVID-19. https:\/\/bit.ly\/3wLbZqp (10)."},{"key":"45520_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2217\/fvl-2020-0129","volume":"15","author":"A Bahrami","year":"2020","unstructured":"Bahrami, A. & Ferns, G. Genetic and pathogenic characterization of SARS-CoV-2: A review. Future Virol. 15, 553\u2013559. https:\/\/doi.org\/10.2217\/fvl-2020-0129 (2020).","journal-title":"Future Virol."},{"key":"45520_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13662-019-2087-3","volume":"2019","author":"GT Tilahun","year":"2019","unstructured":"Tilahun, G. T. Modeling co-dynamics of pneumonia and meningitis diseases. Adv. Differ. Equ. 2019, 1\u201318 (2019).","journal-title":"Adv. Differ. Equ."},{"key":"45520_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.apm.2019.08.012","volume":"77","author":"A Omame","year":"2020","unstructured":"Omame, A., Okuonghae, D., Umana, R. & Inyama, S. Analysis of a co-infection model for HPV-TB. Appl. Math. Model. 77, 881\u2013901 (2020).","journal-title":"Appl. Math. Model."},{"key":"45520_CR22","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.17762\/turcomat.v12i2.1814","volume":"12","author":"KG Varshney","year":"2021","unstructured":"Varshney, K. G. & Dwivedi, Y. K. Mathematical modelling of influenza-meningitis under the quarantine effect of influenza. Turkish J. Comput. Math. Educ. (TURCOMAT) 12, 7214\u20137225 (2021).","journal-title":"Turkish J. Comput. Math. Educ. (TURCOMAT)"},{"key":"45520_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/oca.2717","volume":"42","author":"A Omame","year":"2021","unstructured":"Omame, A. & Okuonghae, D. A co-infection model for oncogenic human papillomavirus and tuberculosis with optimal control and cost-effectiveness analysis. Optim. Control Appl. Methods 42, 1081\u20131101 (2021).","journal-title":"Optim. Control Appl. Methods"},{"key":"45520_CR24","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1186\/s13662-021-03271-6","volume":"1\u201330","author":"IM Hezam","year":"2021","unstructured":"Hezam, I. M., Foul, A. & Alrasheedi, A. A dynamic optimal control model for COVID-19 and cholera co-infection in Yemen. Adv. Differ. Equ. 1\u201330, 2021. https:\/\/doi.org\/10.1186\/s13662-021-03271-6 (2021).","journal-title":"Adv. Differ. Equ."},{"key":"45520_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.apm.2021.06.016","volume":"99","author":"S Tchoumi","year":"2021","unstructured":"Tchoumi, S., Diagne, M., Rwezaura, H. & Tchuenche, J. Malaria and COVID-19 co-dynamics: A mathematical model and optimal control. Appl. Math. Model. 99, 294\u2013327. https:\/\/doi.org\/10.1016\/j.apm.2021.06.016 (2021).","journal-title":"Appl. Math. Model."},{"key":"45520_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/oca.2748","author":"A Omame","year":"2020","unstructured":"Omame, A. et al. Analysis of COVID-19 and comorbidity co-infection model with optimal control. Optim. Control Appl. Methodshttps:\/\/doi.org\/10.1002\/oca.2748 (2020).","journal-title":"Optim. Control Appl. Methods"},{"key":"45520_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2449710","volume":"8","author":"KG Mekonen","year":"2022","unstructured":"Mekonen, K. G. & Obsu, L. L. Mathematical modeling and analysis for the co-infection of COVID-19 and tuberculosis. Heliyon 8, e11195. https:\/\/doi.org\/10.1155\/2022\/2449710 (2022).","journal-title":"Heliyon"},{"key":"45520_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.rinp.2022.105481","volume":"37","author":"A Omame","year":"2022","unstructured":"Omame, A., Abbas, M. & Onyenegecha, C. P. Backward bifurcation and optimal control in a co-infection model for SARS-CoV-2 and ZIKV. Results Phys. 37, 105481 (2022).","journal-title":"Results Phys."},{"key":"45520_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.physa.2023.128607","volume":"615","author":"A Omame","year":"2023","unstructured":"Omame, A. & Abbas, M. Modeling SARS-CoV-2 and HBV co-dynamics with optimal control. Physica A: Stat. Mech. Appl. 615, 128607 (2023).","journal-title":"Physica A: Stat. Mech. Appl."},{"key":"45520_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/oca.2936","volume":"44","author":"A Omame","year":"2023","unstructured":"Omame, A., Isah, M. E. & Abbas, M. An optimal control model for COVID-19, zika, dengue, and chikungunya co-dynamics with reinfection. Optim. Control Appl. Methods 44, 170\u2013204 (2023).","journal-title":"Optim. Control Appl. Methods"},{"key":"45520_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1140\/epjp\/s13360-022-02387-2","volume":"137","author":"A Elaiw","year":"2022","unstructured":"Elaiw, A., Al Agha, A., Azoz, S. & Ramadan, E. Global analysis of within-host SARS-CoV-2\/HIV coinfection model with latency. Eur. Phys. J. Plus 137, 1\u201322. https:\/\/doi.org\/10.1140\/epjp\/s13360-022-02387-2 (2022).","journal-title":"Eur. Phys. J. Plus"},{"key":"45520_CR32","doi-asserted-by":"publisher","first-page":"9715","DOI":"10.1016\/j.aej.2022.03.013","volume":"61","author":"A Omame","year":"2022","unstructured":"Omame, A., Isah, M. E., Abbas, M., Abdel-Aty, A.-H. & Onyenegecha, C. P. A fractional order model for dual variants of COVID-19 and HIV co-infection via Atangana\u2013Baleanu derivative. Alex. Eng. J. 61, 9715\u20139731. https:\/\/doi.org\/10.1016\/j.aej.2022.03.013 (2022).","journal-title":"Alex. Eng. J."},{"key":"45520_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2022.100978","volume":"31","author":"N Ringa","year":"2022","unstructured":"Ringa, N. et al. HIV and COVID-19 co-infection: A mathematical model and optimal control. Inform. Med. Unlocked 31, 100978. https:\/\/doi.org\/10.1016\/j.imu.2022.100978 (2022).","journal-title":"Inform. Med. Unlocked"},{"key":"45520_CR34","doi-asserted-by":"publisher","first-page":"2175920","DOI":"10.1080\/17513758.2023.2175920","volume":"17","author":"SW Teklu","year":"2023","unstructured":"Teklu, S. W. & Kotola, B. S. A dynamical analysis and numerical simulation of COVID-19 and HIV\/AIDS co-infection with intervention strategies. J. Biol. Dyn. 17, 2175920 (2023).","journal-title":"J. Biol. Dyn."},{"key":"45520_CR35","unstructured":"Organization, W.\u00a0H. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017 (World Health Organization, 2017)."},{"key":"45520_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","volume":"180","author":"P Van den Driessche","year":"2002","unstructured":"Van den Driessche, P. & Watmough, J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180, 29\u201348. https:\/\/doi.org\/10.1016\/S0025-5564(02)00108-6 (2002).","journal-title":"Math. Biosci."},{"key":"45520_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3934\/mbe.2004.1.361","volume":"1","author":"C Castillo-Chavez","year":"2004","unstructured":"Castillo-Chavez, C. & Song, B. Dynamical models of tuberculosis and their applications. Math. Biosci. Eng. 1, 361 (2004).","journal-title":"Math. Biosci. Eng."},{"key":"45520_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-7612-3","volume-title":"An Introduction to Mathematical Epidemiology","author":"M Martcheva","year":"2015","unstructured":"Martcheva, M. An Introduction to Mathematical Epidemiology Vol. 61 (Springer, 2015)."},{"key":"45520_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/00029890.2004.11920108","volume":"111","author":"X Wang","year":"2004","unstructured":"Wang, X. A simple proof of Descartes\u2019s rule of signs. Am. Math. Mon. 111, 525 (2004).","journal-title":"Am. Math. Mon."},{"key":"45520_CR40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1109\/TCT.1960.1086720","volume":"7","author":"J LaSalle","year":"1960","unstructured":"LaSalle, J. Some extensions of Liapunov\u2019s second method. IRE Trans. Circuit Theory 7, 520\u2013527. https:\/\/doi.org\/10.1109\/TCT.1960.1086720 (1960).","journal-title":"IRE Trans. Circuit Theory"},{"key":"45520_CR41","first-page":"31","volume":"125","author":"CC Chavez","year":"2002","unstructured":"Chavez, C. C., Feng, Z. & Huang, W. On the computation of $$\\cal{R} _0$$ and its role on global stability. Math. Approaches Emerg. Re-emerg. Infect. Dis.: Introd. 125, 31\u201365 (2002).","journal-title":"Math. Approaches Emerg. Re-emerg. Infect. Dis.: Introd."},{"key":"45520_CR42","unstructured":"EPHI. Covid-19 pandemic preparedness and response in ethiopia. https:\/\/ephi.gov.et\/download\/pheoc\/ (2022). (accessed 20 may 2022)."},{"key":"45520_CR43","unstructured":"scipy.org. scipy.optimize.curve_fit. https:\/\/docs.scipy.org\/doc\/scipy\/reference\/generated\/scipy.optimize.curve_fit.html (2021). (accessed 01 September 2021)."},{"key":"45520_CR44","unstructured":"The World Bank. Population ethiopia. https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL (2022)."},{"key":"45520_CR45","unstructured":"Institute, E. P.\u00a0H. HIV related estimates and projections in Ethiopia for the year 2021\u20132022 (2022)."},{"key":"45520_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mbs.2015.10.008","volume":"271","author":"N Hussaini","year":"2016","unstructured":"Hussaini, N., Lubuma, J. M., Barley, K. & Gumel, A. Mathematical analysis of a model for AVL-HIV co-endemicity. Math. Biosci. 271, 80\u201395. https:\/\/doi.org\/10.1016\/j.mbs.2015.10.008 (2016).","journal-title":"Math. Biosci."},{"key":"45520_CR47","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.2147\/IDR.S277899","volume":"14","author":"N Squillace","year":"2021","unstructured":"Squillace, N., Ricci, E., Colella, E. & Bonfanti, P. HIV and SARS-CoV-2 Co-Infection: What are the risks?. Infect. Drug Resist. 14, 3991. https:\/\/doi.org\/10.2147\/IDR.S277899 (2021).","journal-title":"Infect. Drug Resist."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45520-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:06:34Z","timestamp":1698411994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45520-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45520"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45520-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18437"}}